The Russian Federation’s Industry and Trade Ministry is set to introduce the latest scientific research on drugs, with an aim to help innovative developments enter Russia and western markets.
As part of this initiative, a new programme has been launched to promote, expert trials and analytical support, as well as business acceleration for research projects that previously received state funding.
This programme of the sixth Russian-Swedish economic forum on new investment potential will include a presentation of the project office and Russian innovative projects in pharmaceuticals and biotechnologies.
An example of such developments is the project by the private think tank Biomedical Centre of St Petersburg.
The centre researches the role of epidemiological approaches in the fight against HIV and AIDS and develops new concepts of active preventative measures.
It developed some of the potential vaccines that have successfully passed their pre-clinical and clinical trials and are currently awaiting state support for conducting Phase II and III clinical trials.
Designed to support the development of successful research, the new programme will reassess the projects’ viability and analyse their technological and economic potential for scaling in Russia, as well as overseas.
The Russian ministry plans to expand the work of the independent project reviewing commission next year.
